Deadline for manuscript submissions: 30 November 2024

 

Special Issue Editors

Ansheng Zhang Website  E-Mail: anshengzhang867@gmail.com

International Medical Center Hospital, China
Interests: medical sciences; biotechnology; molecular basis

Gaurav Goyal Website  E-Mail: dr.gaurav867@gmail.com
Guest Editor
Genesis Institute of Dental Sciences and Research, India
Interests: oncology; head and neck cancer; clinical study

Dibyajit LAHIRI Website  E-Mail: deptomr@gmail.com
Guest Editor
Department of Biotechnology at UEM Kolkata, India
Interests: biotechnology; cellular medicine; cancer informatics

Batol Imran Dheeb Website  E-Mail:Batoolomran@yahoo.com
Guest Editor
Samara university college of applied science, Pathological analysis department
Interests: biotechnology; cellular medicine; cancer informatics

 

Special Issue Information

Dear colleagues,

Epigenetic mechanisms, such as DNA methylation, histone post-translational modifications, and chromatin structure regulation, play a crucial role in the interactions between tumor and immune cells. Emerging evidence indicates that tumors often exploit various epigenetic mechanisms to evade immune detection and suppression. Consequently, the pharmaceutical modulation of epigenetic regulators—including ‘writers’, ‘readers’, ‘erasers’, and ‘remodelers’—has the potential to restore impaired immunosurveillance and/or initiate antitumor immune responses. Thus, epigenetic targeting agents represent promising immunomodulatory drugs with significant impacts on immuno-oncology.

This special issue focuses on the cutting-edge research and technological advancements in the fields of cancer immunology, gene editing, and epigenetics. It aims to provide a comprehensive platform for scientists and clinicians to share their latest findings, discuss the challenges, and explore the future directions in these rapidly evolving areas. Topics of interest include, but are not limited to:

Novel immunotherapeutic strategies and their clinical applications in cancer treatment
CRISPR/Cas9 and other gene editing technologies in cancer research and therapy
Epigenetic modifications and their role in cancer development and progression
Biomarker discovery and personalized medicine approaches in oncology
Combination therapies involving immunotherapy, gene editing, and epigenetic modulation
Mechanistic insights into tumor-immune interactions and resistance to therapy
Translational studies and clinical trials highlighting innovative cancer treatments

We invite researchers, clinicians, and scholars to contribute original research articles, reviews, case studies, and perspectives that address these key areas, with the goal of advancing our understanding and treatment of cancer.

Ansheng Zhang
Gaurav Goyal
Dibyajit LAHIRI
Guest Editors

 

Keywords

- Epigenetic mechanisms
- DNA methylation
- Histone modifications
- Chromatin structure
- Tumor immune evasion
- Immunosurveillance
- Epigenetic regulators
- Immunomodulatory drugs
- Cancer-immunity cycle
- Anticancer immune responses
- Immunotherapy
- Epigenetic therapy
- Tumor microenvironment
- Immune cell interactions

 

Published Papers